Effect of perindopril/amlodipine administered as fixed dose combination in patients with arterial hypertension and ischemic heart disease.

Trial Profile

Effect of perindopril/amlodipine administered as fixed dose combination in patients with arterial hypertension and ischemic heart disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Nov 2016

At a glance

  • Drugs Perindopril/amlodipine (Primary) ; Indapamide
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Nov 2016 location is assumed
    • 12 Nov 2016 New trial record
    • 29 Sep 2016 Primary endpoint (BP lowering) has been met as per results presented at the 26th Scientific Meeting of the International Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top